Pharma News

Drug price regulator NPPA announced provisional maximum prices for 761 drugs, including anticancer drugs, HIV, diabetes and antibiotics, with a majority being reduced ahead of the GST implementation.

[adsense:336x280:8701650588]

Noncommunicable diseases (NCDs) kill 40 million people each year, says the World Health Organization (WHO). Noncommunicable diseases (NCDs), also known as chronic diseases, tend to be long-lasting and are the result of a combination of genetic, physiological, environmental and behavioral factors.

The Cabinet of the Union approved the signing of a memorandum of understanding for cooperation between India and Sri Lanka in traditional medical systems. The Memorandum of Understanding between the Ministry of AYUSH and the Ministry of Health, Nutrition and Indigenous Medicines of Sri Lanka will enhance bilateral cooperation in traditional medicine and homeopathy, an official statement said.

Sun Pharmaceutical Industries Ltd and includes its subsidiaries or associate companies) and The National Institute of Virology (NIV), Pune, an institution of the Indian Council of Medical Research, Department of Health Research, Ministry of Health and Family Welfare , New Delhi announced that they have signed an agreement for testing phytopharmaceutical, biologic and chemical entities developed by Sun Pharma against Zika, Chikungunya and Dengue viruses. Sun Pharma will provide drug molecules to NIV for testing against Zika, Chikungunya and Dengue in model systems.

ChromaDex Corp.an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions for dietary supplement, food and beverage, skin care, sports nutrition, and pharmaceutical products announced today that it has signed a new, exclusive patent license and research agreement with The Scripps Research Institute (TSRI), gaining access to groundbreaking, pre-clinical discoveries by Dr. Brunie Felding.  

pSivida Corp. a leader in the development of sustained release drug products and technologies,  announced the Company’s second Phase 3 trial of Durasert three-year treatment for posterior segment uveitis achieved the trial’s primary endpoint. The study involved 153 patients and the primary endpoint was prevention of recurrence of posterior uveitis at six months with patients continuing to be followed for 36 months.

The Department of Pharmaceutical Products (DoP) has set up a GST facilitation center to enable pharmaceutical companies to successfully implement the new tax regime.

President Pranab Mukherjee lamented the lack of infrastructure and health personnel in the country, particularly in rural areas, and expressed hope that more investment would help bridge the gap.

The Center has asked the Indian Council for Medical Research (ICMR) to carry out a detailed study to assess whether there is any leaching of plastic bottles into the liquid medicine formulations stored in them.

The CSIR-Central Drugs Research Institute (CDRI) will inform Prime Minister Narendra Modi about three new drugs being developed by the Institute during its visit to the campus. Modi is also president of the Scientific and Industrial Research Council (CSIR) and this will be his first visit to any of his laboratories in the country. The institute is also organizing an exhibition to highlight the CDRI's contribution to the discovery and development of PM medications.